M&A Deal Summary |
|
|---|---|
| Date | 2020-12-28 |
| Target | International Health Group |
| Sector | Healthcare Services |
| Buyer(s) | Dalrada Health |
| Deal Type | Add-on Acquisition |
SEARCH BY
Dalrada Health is focused on solving health problems around the world by developing products and services that address the unmet needs of consumers due to accessibility, affordability, or availability. With operations in the U.S., Malaysia, and India, Dalrada Health can reach underserved markets through strong partnerships and the development of efficient supply chains. Dalrada Health is committed to solving universal health problems through improved methodologies resulting in products and services that benefit the global marketplace.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: California M&A | 2 of 2 |
| Country: United States M&A | 2 of 2 |
| Year: 2020 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-28 |
Pacific Stem Cells
Newport Beach, California, United States Pacific Stem Cells LLC is located in Newport Beach, California. The Company intends to set a new standard for the highest quality, laboratory tested stem cells, timely delivery, telemedicine portal, treatment protocols, management services, physician and staff education. Pacific Stem Cells offers a variety of regenerative medical procedures to support orthopedics, arthritis, heart disease, and auto-immune diseases. |
Buy | - |
